Literature DB >> 21035497

Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: role of Akt/mTOR and MAPK pathways.

Meena Jhanwar-Uniyal1, Ladislau Albert, Elise McKenna, Michael Karsy, Priya Rajdev, Alex Braun, Raj Murali.   

Abstract

These findings emphasize that the mTOR pathway may contribute to maintenance of quiescence of CSCs, and provide a basis for manipulating CSCs in the treatment of GBM. Future research should focus on further defining the PI3K/Akt/mTOR molecular network in the regulation of stem cell quiescence and provide rationale for targeting the cancer-initiating cells of GBM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21035497     DOI: 10.1016/j.advenzreg.2010.09.017

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


  7 in total

1.  Identification of expression quantitative trait loci of RPTOR for susceptibility to glioma.

Authors:  Liming Huang; Wenshen Xu; Danfang Yan; Lian Dai; Xi Shi
Journal:  Tumour Biol       Date:  2015-09-11

2.  The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.

Authors:  Michael Karsy; Ladislau Albert; Raj Murali; Meena Jhanwar-Uniyal
Journal:  Tumour Biol       Date:  2014-01-08

Review 3.  Glioblastoma: molecular pathways, stem cells and therapeutic targets.

Authors:  Meena Jhanwar-Uniyal; Michael Labagnara; Marissa Friedman; Amanda Kwasnicki; Raj Murali
Journal:  Cancers (Basel)       Date:  2015-03-25       Impact factor: 6.639

4.  PIM1 Inhibition Affects Glioblastoma Stem Cell Behavior and Kills Glioblastoma Stem-like Cells.

Authors:  Carolin Seifert; Ellen Balz; Susann Herzog; Anna Korolev; Sebastian Gaßmann; Heiko Paland; Matthias A Fink; Markus Grube; Sascha Marx; Gabriele Jedlitschky; Mladen V Tzvetkov; Bernhard H Rauch; Henry W S Schroeder; Sandra Bien-Möller
Journal:  Int J Mol Sci       Date:  2021-10-15       Impact factor: 5.923

Review 5.  Breaking Bad: Autophagy Tweaks the Interplay Between Glioma and the Tumor Immune Microenvironment.

Authors:  Yuxiang Fan; Yubo Wang; Jian Zhang; Xuechao Dong; Pu Gao; Kai Liu; Chengyuan Ma; Gang Zhao
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

6.  PP242 suppresses cell proliferation, metastasis, and angiogenesis of gastric cancer through inhibition of the PI3K/AKT/mTOR pathway.

Authors:  Xiaofang Xing; Lianhai Zhang; Xianzi Wen; Xiaohong Wang; Xiaojing Cheng; Hong Du; Ying Hu; Lin Li; Bin Dong; Ziyu Li; Jiafu Ji
Journal:  Anticancer Drugs       Date:  2014-11       Impact factor: 2.248

7.  Targeting the mTOR pathway using novel ATP‑competitive inhibitors, Torin1, Torin2 and XL388, in the treatment of glioblastoma.

Authors:  Anubhav G Amin; Seung Won Jeong; John L Gillick; Tolga Sursal; Raj Murali; Chirag D Gandhi; Meena Jhanwar-Uniyal
Journal:  Int J Oncol       Date:  2021-09-15       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.